GENELUX Corp (GNLX)
Latest GNLX Insider Trades
- Yong Yu - OfficerOpen-market sale$2K
Joseph Cappello - Officer
About GENELUX Corp (GNLX)
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
- WESTLAKE VILLAGE, CA
- 26
- 2023
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 26,521 | $78K |
| Grant or award | 13 | 1,777,523 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
GNLX Insider Transactions (Form 4)
4266 Form 4 filings on record, the earliest from Oct 21, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yong Yu - Officer | Open-market sale | Common Stock | 653 |
Recent GNLX Form 8-K Filings
2Recent GNLX Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - |
GNLX Insider Trading - FAQ
What is the latest insider trade for GNLX?
GENELUX Corp (GNLX) had 15 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for GNLX runs to 66 Form 4 filings, the earliest from 2024-10-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying GNLX stock?
No insider purchases of GNLX were filed in the last 90 days.
How many insiders are selling GNLX stock?
6 insider sales of GNLX were filed in the last 90 days, totaling $78K.
Where can I see GNLX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks GNLX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow GNLX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add GNLX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Yong Yu view on EDGAR
- - Joseph Cappello view on EDGAR
- - Thomas Zindrick view on EDGAR
- - John W. Smither view on EDGAR
- - Matthew Pulisic view on EDGAR
- - Eric Groen view on EDGAR
- - Joseph Cappello view on EDGAR
- - James L. Tyree view on EDGAR
- - Thomas Zindrick view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where GNLX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track GNLX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
